PAVMW (PAVmed) Short-Term Debt: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAVMW PAVmed Inc PAVMW
32 GF Score
Price $0.03
! 6 Warning Signs
View Full Analysis

What is PAVmed Short-Term Debt?

PAVmed PAVMW 32 Short-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus rates PAVMW with a GF Score™ of 32/100. The stock has 6 warning signs investors should review.

PAVmed's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.00 Mil.

PAVmed's quarterly Short-Term Debt increased from Sep. 2025 ($6.90 Mil) to Dec. 2025 ($11.10 Mil) but then declined from Dec. 2025 ($11.10 Mil) to Mar. 2026 ($0.00 Mil).

PAVmed's annual Short-Term Debt declined from Dec. 2023 ($44.20 Mil) to Dec. 2024 ($29.10 Mil) and declined from Dec. 2024 ($29.10 Mil) to Dec. 2025 ($11.10 Mil).

PAVmed Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PAVmed Short-Term Debt Related Terms

PAVmed Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PAVmed's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PAVmed Short-Term Debt Chart

PAVmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 33.65 44.20 29.10 11.10

PAVmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.60 6.80 6.90 11.10 0.00
PAVMW
32GF Score
PAVmed Inc PAVMW
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.00 Mil mean?
PAVmed (PAVMW) has a Short-Term Debt of $0.00 Mil as of Mar. 2026.
Is PAVmed's Short-Term Debt too high?
PAVmed's current Short-Term Debt is $0.00 Mil. Overall, PAVmed has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PAVmed's Short-Term Debt compare to BDMD and TELA?
PAVmed's Short-Term Debt of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PAVmed's current Short-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAVmed stock overvalued right now?
PAVmed (PAVMW) has a current Short-Term Debt of $0.00 Mil. The current Short-Term Debt is $0.00 Mil. PAVmed's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PAVmed (PAVMW), the current Short-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PAVmed Business Description

Other Exchanges PAVM:USA
Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
32GF Score

Get the complete analysis for PAVMW

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price